Phase II study of combination 4'-epidoxorubicin and mitomycin C in recurrent epithelial ovarian cancer.

Redman, C; Lawton, F; Stuart, N; O'Brien, M; Buxton, J; Mould, J; Chetiyawardana, A; Crawford, M; Patterson, M; Sykes, V

Redman, C; Lawton, F; Stuart, N; O'Brien, M; Buxton, J; Mould, J; Chetiyawardana, A; Crawford, M; Patterson, M; Sykes, V.

Affiliation

Redman C; West Midlands CRC Clinical Trials Unit, Queen Elizabeth Medical Centre, Birmingham, U.K.

Cancer Chemother Pharmacol ; 23(1): 51-3, 1989.

Article in En | MEDLINE | ID: mdl-2491794

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Epirubicin/administration & dosage; Mitomycins/administration & dosage; Neoplasm Recurrence, Local/drug therapy; Ovarian Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Drug Evaluation; Female; Humans; Middle Aged; Mitomycin

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Ovarian Neoplasms / Epirubicin / Antineoplastic Combined Chemotherapy Protocols / Mitomycins / Neoplasm Recurrence, Local Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 1989 Type: Article

Search on Google

XML

PubMed Links